The purpose of the study is to demonstrate the superiority of mesalazine granules compared to placebo in terms of the primary efficacy variable proportion of recurrence-free patients within 48 weeks.
The purpose of the study is to determine whether mesalazine granules compared to placebo is effective in prevention of recurrence of disease.